This announcement is a separate document:
上海荣正企业咨询服务（集团）股份有限公司关于安徽华恒生物科技股份有限公司2021年限制性股票激励计划第二个解除限售期解除限售条件成就及第二个归属期归属条件成就事项之独立财务顾问报告
Independent financial advisor report on the achievement of the second release condition and the second attribution condition of Anhui Huaheng Biotechnology Co., Ltd.'s 2021 restricted stock incentive plan by Shanghai Rongzheng Enterprise Consulting Services (Group) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.